Home » Topics » Regulatory

Regulatory
RSS

Antileukemic effects described for vesnarinone

Nov. 28, 1997

Immunex seeks FDA approval for generic paclitaxel injection

Nov. 28, 1997

First anticancer monoclonal antibody approved by FDA

Nov. 27, 1997

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Nov. 27, 1997

Forest files for FDA approval of Synapton

Nov. 26, 1997

First marketing approval granted for Neumega

Nov. 26, 1997

Extended-release Effexor introduced in U.S. for depression

Nov. 26, 1997

Neuroprotective efficacy of lamotrigine in rat cardiac arrest model

Nov. 25, 1997

FDA approves sibutramine for the treatment of obesity

Nov. 25, 1997

Fixed-dose trandolapril/verapamil combination now available in U.K.

Nov. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...